Pages Tagged with "Press Release"

Eight cancer survivors celebrate life and perseverance on City of Hope’s Rose Parade float
•    2024 marks the 50th anniversary of City of Hope’s participation in the Rose Parade®•    City of Hope’s float “A Lovely Day for Hope” features patients who overcame unique obstacles to...
City of Hope presents research at American Society of Hematology conference on mosunetuzumab plus polatuzumab vedotin for patients with relapsed or refractory large B cell lymphoma
The research also published simultaneously in Nature MedicineCONTACTLetisia Marquezlemarquez@coh.org(626) 476-7593LOS ANGELES -- New therapies for patients with relapsed or drug-resistant large B cell lymphoma remain...
City of Hope presents pivotal clinical trial data at American Society of Hematology (ASH) conference on revumenib, a potential new targeted therapy for high-risk subtypes of acute leukemias
Revumenib met its primary endpoint for efficacy in pivotal Phase 2 AUGMENT-101 trial and demonstrated favorable safety and tolerability in adult and pediatric patients with relapsed/refractory KMT2A-rearranged (KMT2Ar) acute myeloid...
City of Hope scientists present promising new research at American Society of Hematology Annual Meeting
CONTACTLetisia Marquez626-476-7593lemarquez@coh.orgResearch addresses potential blood-cancer immunotherapies, DNA vaccines and treatments aimed at preventing CAR T  cell therapy relapse and resistanceLOS ANGELES — Physicians and scientists...
City of Hope doctors and scientists present innovative research at largest gathering on breast cancer research
CONTACTLetisia Marquez626-476-7593lemarquez@coh.orgResearch topics include the use of estrogen therapy in postmenopausal women, City of Hope’s Couples Coping With Cancer Together and genetic testingLOS...
RESEARCH ALERT: Why it’s important to improve communication of unanticipated genomic findings to patients with late-stage cancer
New research conducted by City of Hope and supported by the American Cancer Society focuses on developing scalable educational interventions to support informed patient decision making and consent, such as...
City of Hope appoints Alan H. Bryce, M.D., as chief clinical officer at City of Hope Cancer Center Phoenix and professor of molecular medicine at TGen
CONTACTNoah Flack602-883-1300noah.flack@coh.orgGalen Perry602-343-8423gperry@tgen.org  City of Hope appoints Alan H. Bryce, M.D., as chief clinical officer at City of Hope Cancer Center Phoenix and professor of molecular medicine at TGen.  PHOENIX — He joins City of Hope® from Mayo Clinic, where he served as chair of the Division...
City of Hope Vice Physician-in-Chief Edward S. Kim, M.D., M.B.A, Recognized as a Top Diversity Leader in U.S. Healthcare
Kim is honored by Modern Healthcare magazine for lifelong advocacy for equity in cancer research and care CONTACT Kelsey Dalton626-595-0011  kdalton@coh.org LOS ANGELES — City of Hope...
City of Hope part of successful international Phase 3 clinical trial evaluating sotorasib medication combination for patients with metastatic colorectal cancer
The novel therapeutic tested at City of Hope could provide a new option for patients with a treatment-resistant tumor mutation called KRAS G12CCONTACTZen Logsdon626-409-9367zlogsdon@coh.org 
City of Hope, TGen awarded five-year, $4.5 million grant to advance liquid biopsy for pancreatic cancer
•    City of Hope-led consortium seeks to validate noninvasive screening test for pancreatic ductal adenocarcinoma through large-scale cohort •    Inclusion of diverse populations is crucial for advancing understanding of these...
Subscribe to Press Release